Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 7271-7280 of 11992

Page
per page
  1. TACA
    B6217 TACA
    Summary: GABAA agonist
      Soluble to 100 mM in H2O
  2. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     15 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL
  3. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  4. BEZ235 (NVP-BEZ235)
    A8246 BEZ235 (NVP-BEZ235)
     2 Citation
    Summary: PI3K/mTOR inhibitor,ATP-competitve
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  5. BTZ043 Racemate
    A5118 BTZ043 Racemate
     2 Citation
    Target: DprE
    Summary: DprE1 inhibitor
      insoluble in H2O; ≥10.4 mg/mL
  6. tumor protein p53 binding protein fragment [Homo sapiens]/[Mus musculus]
    A1094 tumor protein p53 binding protein fragment [Homo sapiens]/[Mus musculus]
    Summary: P53 binding protein fragment
      ≥124.2 mg/mL
  7. 2-Cl-IB-MECA
    B6597 2-Cl-IB-MECA
    Summary: A3 adenosine receptor agonist
      ≥54.5 mg/mL
  8. IDRA 21
    B6639 IDRA 21
    Summary: Inhibits AMPA receptor desensitization
      Soluble to 100 mM in DMSO
  9. Ciglitazone
    B6681 Ciglitazone
    Summary: PPARγ agonist
  10. MG 624
    B6701 MG 624
    Summary: neuronal α7 nAChR antagonist
      Soluble in DMSO

Items 7271-7280 of 11992

Page
per page